BIOLIFE SOLUTIONS INC 3 SEC Filings

Filed On	Filing
20 Mar 2025	Form 3: Coste Catherine, Director No securities owned
10 Jan 2025	Form 3: Hunt Anthony, Director No securities owned
06 Dec 2024	Form 3: Werner Sean, Chief Technology Officer Holds 5,089 shares of Common Stock
01 Nov 2023	Form 3: Richardson Garrie, Chief Revenue Officer Holds 69,007 shares of Common Stock
09 Jan 2023	Form 3: Phillips Geraint, SVP, Global Operations Holds 38,362 shares of Common Stock
06 Sep 2022	Form 3: Moore Timothy L., Director No securities owned
15 Nov 2021	Form 3: Wichterman Troy, Chief Financial Officer Holds 1,286 shares of Common Stock
07 Oct 2021	Form 3: Goswami Joydeep, Director No securities owned
13 May 2021	Form 3: Tenney Dusty, COO and President No securities owned
08 Apr 2021	Form 3: Ellingson Rachel, Director No securities owned
08 Apr 2021	Form 3: DuRoss Amy, Director No securities owned
07 Jan 2021	Form 3: Aebersold Sarah, VP, Global Human Resources Holds 18,104 shares of Common Stock
28 May 2020	Form 3: Schulz Marcus, Vice President, Global Sales Holds 129 shares of Common Stock
15 Aug 2018	Form 3: Casdin Partners Master Fund, L.p., 10% owner and 3 others Holds 2,428,571 shares of Common Stock, par value $0.001 per share
26 Aug 2016	Form 3: Foster Karen A., Vice President of Operations No securities owned
02 Jun 2016	Form 3: Mathers James, Vice President of Sales No securities owned
07 Mar 2016	Form 3: De Greef Roderick, Interim CFO & Interim Sec. No securities owned
24 Feb 2015	Form 3: Berard Todd, V.P. Marketing
24 Feb 2015	Form 3: Snyder Matt, V.P. Global Sales Holds 2,381 shares of Common Stock
26 Mar 2014	Form 3: Taurus4757 GmbH, 10% owner Holds 1,544,194 shares of Common Stock

Comments